Evidence map›Paper›PMID 35420793›Full record

ArticleBiochemistry2022

Structural Basis for Reduced Dynamics of Three Engineered HNH Endonuclease Lys-to-Ala Mutants for the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Associated 9 (CRISPR/Cas9) Enzyme.

Jimin Wang, Erin Skeens, Pablo R Arantes, Federica Maschietto, Brandon Allen, Gregory W Kyro, George P Lisi, Giulia Palermo, Victor S Batista

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jimin WangDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520-8114, United States.ORCID 0000-0002-4504-8038
Erin SkeensDepartment of Molecular and Cell Biology and Biochemistry, Brown University, Providence, Rhode Island 02912, United States.
Pablo R ArantesDepartment of Bioengineering and Department of Chemistry, University of California Riverside, Riverside, California 92521-9800, United States.ORCID 0000-0003-1946-2750
Federica MaschiettoDepartment of Chemistry, Yale University, New Haven, Connecticut 06511-8499, United States.ORCID 0000-0002-5995-2765
Brandon AllenDepartment of Chemistry, Yale University, New Haven, Connecticut 06511-8499, United States.ORCID 0000-0002-5512-1892
Gregory W KyroDepartment of Chemistry, Yale University, New Haven, Connecticut 06511-8499, United States.ORCID 0000-0002-0095-8548
George P LisiDepartment of Molecular and Cell Biology and Biochemistry, Brown University, Providence, Rhode Island 02912, United States.ORCID 0000-0001-8878-5655
Giulia PalermoDepartment of Bioengineering and Department of Chemistry, University of California Riverside, Riverside, California 92521-9800, United States.ORCID 0000-0003-1404-8737
Victor S BatistaDepartment of Chemistry, Yale University, New Haven, Connecticut 06511-8499, United States.ORCID 0000-0002-3262-1237
Yale University · USBrown University · USUniversity of California, Riverside · US

Funding

Predoctoral Program in BiophysicsT32GM149438 · NIGMS · YALE UNIVERSITY · PI Yong Xiong, Elsa Chui Ying Yan · 2023 to 2026
$2.6M
Investigating the metal-dependent function, allostery and inhibition of CRISPR-Cas9R01GM141329 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI PALERMO, GIULIA · 2021 to 2025
$1.7M
Studies of Allostery between Multi-domain Proteins and Nucleic Acid ComplexesR01GM136815 · NIGMS · YALE UNIVERSITY · PI BATISTA, VICTOR S · 2021 to 2024
$1.4M
NIGMS NIH HHS R01 GM136815NIGMS NIH HHS R01 GM141329NIGMS NIH HHS T32 GM149438
6 · The paper itself

Abstract

Many bacteria possess type-II immunity against invading phages or plasmids known as the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) system to detect and degrade the foreign DNA sequences. The Cas9 protein has two endonucleases responsible for double-strand breaks (the HNH domain for cleaving the target strand of DNA duplexes and RuvC domain for the nontarget strand, respectively) and a single-guide RNA-binding domain where the RNA and target DNA strands are base-paired. Three engineered single Lys-to-Ala HNH mutants (K810A, K848A, and K855A) exhibit an enhanced substrate specificity for cleavage of the target DNA strand. We report in this study that in the wild-type (wt) enzyme, D835, Y836, and D837 within the Y836-containing loop (comprising E827-D837) adjacent to the catalytic site have uncharacterizable broadened

Indexed as

CRISPR-Cas SystemsEndonucleasesClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Associated Protein 9DNACRISPR-Associated Protein 9DNAEndonucleases

Identifiers

PMID35420793
PMCPMC9069930
OpenAlexW4224039580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.